Omalizumab provides long-term control in patients with moderate-to-severe allergic asthma
No Thumbnail Available
Authors
Buhl, R.
Soler, M.
Matz, J.
Townley, R.
O'Brien, J.
Noga, O.
Champain, K.
Fox, H.
Thirlwell, J.
Della Cioppa, G.
Issue Date
2002
Volume
20
Issue
1
Type
Journal Article
Language
Keywords
Alternative Title
Abstract
Description
Citation
Buhl, R.; Soler, M.; Matz, J.; Townley, R.; O'Brien, J.; Noga, O.; Champain, K.; Fox, H.; Thirlwell, J.; Della Cioppa, G. Omalizumab provides long-term control in patients with moderate-to-severe allergic asthma. European Respiratory Journal. 2002, JUL. 20(1):73-78.
Publisher
License
Journal
Volume
Issue
PubMed ID
DOI
Identifier
ISSN
0904-1850
0903-1936
0903-1936
